EPISODE · Jul 30, 2025 · 4 MIN
Tryptyr Now Available in US
from Eyewire News: The Podcast · host Eyewire News
Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Tryptyr Now Available in US
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m